Found: 26
Select item for more details and to access through your institution.
Severity and organ distribution of graft‐versus‐host disease with post‐transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA‐matched or single‐allele mismatched stem cell transplantation
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 6, p. 776, doi. 10.1111/ejh.14294
- By:
- Publication type:
- Article
Microcytic anemia associated with mTOR or calcineurin inhibition: An unusual situation after allogeneic hematopoietic stem cell transplantation.
- Published in:
- International Journal of Laboratory Hematology, 2020, v. 42, n. 3, p. e141, doi. 10.1111/ijlh.13178
- By:
- Publication type:
- Article
Age, CD34+ cell dose, conditioning and pre‐transplant cytopenias can help predict transfusion support in lymphoma patients undergoing autologous stem cell transplantation.
- Published in:
- Vox Sanguinis, 2023, v. 118, n. 8, p. 681, doi. 10.1111/vox.13486
- By:
- Publication type:
- Article
Low Rate of Invasive Fungal Infections During Induction and Consolidation Chemotherapy for Adults with De Novo Acute Myeloid Leukemia Without Anti-mold Prophylaxis: Single-Center 2002–2018 Empirical/Pre-emptive Approach.
- Published in:
- Mycopathologia, 2020, v. 185, n. 4, p. 639, doi. 10.1007/s11046-020-00461-w
- By:
- Publication type:
- Article
Correction to: mRNA-1273 SARS-CoV-2 vaccine safety and COVID-19 risk perception in recently transplanted allogeneic hematopoietic stem cell transplant recipients.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
mRNA-1273 SARS-CoV-2 vaccine safety and COVID-19 risk perception in recently transplanted allogeneic hematopoietic stem cell transplant recipients.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 12, p. 9687, doi. 10.1007/s00520-022-07376-w
- By:
- Publication type:
- Article
Prognostic heterogeneity of adult B‐cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3‐PBX1 treated with measurable residual disease‐oriented protocols.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. 670, doi. 10.1111/bjh.17844
- By:
- Publication type:
- Article
Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper.
- Published in:
- Infection, 2021, v. 49, n. 2, p. 215, doi. 10.1007/s15010-020-01521-5
- By:
- Publication type:
- Article
When an HLA identical donor is not available in adults with hematological neoplasms: single-center comparison of single-unit cord blood transplantation and haploidentical-related PBSC transplantation with PTCy using a standardized conditioning platform (thiotepa-busulfan-fludarabine).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphomas: a retrospective analysis of 77 cases.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Sequence matters: Total body irradiation (TBI)‐based myeloablative conditioning with post‐transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus TBI.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 1, p. 146, doi. 10.1111/ejh.13978
- By:
- Publication type:
- Article
Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 6, p. 659, doi. 10.1111/ejh.13947
- By:
- Publication type:
- Article
LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1066393
- By:
- Publication type:
- Article
Bone marrow WT1 levels in patients with myeloid neoplasms treated with 5‐azacytidine: Identification of responding patients.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 3, p. 208, doi. 10.1111/ejh.13275
- By:
- Publication type:
- Article
Frequency, characteristics, and outcome of PTLD after allo‐SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH).
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 6, p. 465, doi. 10.1111/ejh.13226
- By:
- Publication type:
- Article
Usefulness of thrombopoietin receptor agonists for persistent clinically relevant thrombocytopenia after allogeneic stem cell transplantation.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 3, p. 407, doi. 10.1111/ejh.13132
- By:
- Publication type:
- Article
Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1389345
- By:
- Publication type:
- Article
Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 10, p. e801, doi. 10.1016/j.clml.2021.06.024
- By:
- Publication type:
- Article
ALL-154: t(1;19)(q23;p13) TCF3-PBX1 May Not Be an Intermediate-Risk Subtype in Adult B-Cell Precursor Acute Lymphoblastic Leukemia Patients Treated With MRD-Oriented Protocols from the PETHEMA Group.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S270, doi. 10.1016/S2152-2650(21)01655-4
- By:
- Publication type:
- Article
Poster: ALL-154: t(1;19)(q23;p13) TCF3-PBX1 May Not Be an Intermediate-Risk Subtype in Adult B-Cell Precursor Acute Lymphoblastic Leukemia Patients Treated With MRD-Oriented Protocols from the PETHEMA Group.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S207, doi. 10.1016/S2152-2650(21)01295-7
- By:
- Publication type:
- Article
Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 10, p. 2066, doi. 10.3390/v15102066
- By:
- Publication type:
- Article
One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00778-3
- By:
- Publication type:
- Article
Outcomes and prognostic factors of adults with refractory or relapsed T‐cell acute lymphoblastic leukemia included in measurable residual disease‐oriented trials.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 529, doi. 10.1002/hon.2910
- By:
- Publication type:
- Article
Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances.
- Published in:
- Transplant Infectious Disease, 2023, v. 25, p. 1, doi. 10.1111/tid.14117
- By:
- Publication type:
- Article
Low Rate of Infectious Enterocolitis in Allogeneic Stem Cell Transplant Recipients with Acute Diarrhea: A Prospective Study by the GETH-TC.
- Published in:
- Acta Haematologica, 2023, v. 146, n. 2, p. 161, doi. 10.1159/000528242
- By:
- Publication type:
- Article